
Trump Administration Executive Order (EO) Tracker
Andrea Pretti
Partner Corporate & Finance
Languages
Italian, English
Recognized as a next generation partner in M&A by The Legal 500 2024, Andrea has also been ranked among the top lawyers for Corporate M&A large deals at the Milano Finanza Legal Awards 2024.
Assistance to Morgan Stanley Infrastructure Partners in a binding sale and purchase agreement involving Finhold's shareholders, the majority owner of Salcef Group, for an investment in Salcef Group.*
Assistance to BC Partners in the €3.06 billion acquisition, together with Bain Capital, of Fedrigoni, a leading Italian producer of value-added papers for luxury packaging and creative solutions.*
Assistance to BC Partners in M&A, financing, capital markets, and regulatory matters for their acquisition of up to a 45% stake in SOFIMA, the holding company of IMA, valued at nearly €2.1 billion.*
Assistance to a consortium led by CVC Capital Partners, PSP Investments, and StepStone in the €3 billion acquisition from the Recordati family of the holding company that owns 51.8% of Recordati.*
Assistance to the Italian Ministry of Economy and Finance in its investment in a KKR-led consortium to acquire TIM's network infrastructure activities, at around €22 billion, including earn-outs.*
Assistance to Eni in its agreement to acquire Neptune Energy Group Limited, an exploration and production company with gas assets in Europe, North Africa, Indonesia, and Australia, for $4.9 billion.*
Assistance to BC Partners and SOFIMA in the mandatory tender offer on all the outstanding shares of IMA S.p.A. for a total value of approximately €946 million.*
Assistance to a global pharma company in the divestments of select OTC and prescription pharmaceutical products in the US$670 million divestment to Orifarm in Europe.*
Assistance to a global pharma company in the divestment of select OTC and prescription pharmaceutical products in the $825 million sale to Hypera Pharma in Brazil, Mexico and other LatAm countries.*
Assistance to a global pharma company in the divestment of select OTC and prescription pharmaceutical products in the US$660 million sale to STADA in Russia, Georgia, and several CIS countries.*
Assistance to a global pharmaceutical company in the divestments of select OTC and prescription pharmaceutical products in the US$200 million divestment to Acino in a number of EMEA countries.*
*Matter handled prior to joining Hogan Lovells.